spacer
spacer

PDBsum entry 1dsa

Go to PDB code: 
dna_rna ligands links
DNA PDB id
1dsa

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
DNA/RNA
Ligands
DSA
PDB id:
1dsa
Name: DNA
Title: (+)-Duocarmycin sa covalently linked to duplex DNA, nmr, 20 structures
Structure: DNA (5'-d( Gp Ap Cp Tp Ap Ap Tp Tp Gp Ap C)-3', 5'- d( Gp Tp Cp Ap Ap Tp Tp Ap Gp Tp C)-3'). Chain: a. Engineered: yes. DNA (5'-d( Gp Ap Cp Tp Ap Ap Tp Tp Gp Ap C)-3', 5'- d( Gp Tp Cp Ap Ap Tp Tp Ap Gp Tp C)-3'). Chain: b. Engineered: yes
Source: Synthetic: yes. Synthetic: yes
NMR struc: 20 models
Authors: P.S.Eis,J.A.Smith,D.A.Case,W.J.Chazin
Key ref:
P.S.Eis et al. (1997). High resolution solution structure of a DNA duplex alkylated by the antitumor agent duocarmycin SA. J Mol Biol, 272, 237-252. PubMed id: 9299351 DOI: 10.1006/jmbi.1997.1223
Date:
08-May-97     Release date:   20-Aug-97    
 Headers
 References

DNA/RNA chains
  G-A-C-T-A-A-T-T-G-A-C 11 bases
  G-T-C-A-A-T-T-A-G-T-C 11 bases

 

 
DOI no: 10.1006/jmbi.1997.1223 J Mol Biol 272:237-252 (1997)
PubMed id: 9299351  
 
 
High resolution solution structure of a DNA duplex alkylated by the antitumor agent duocarmycin SA.
P.S.Eis, J.A.Smith, J.M.Rydzewski, D.A.Case, D.L.Boger, W.J.Chazin.
 
  ABSTRACT  
 
The three-dimensional solution structure of duocarmycin SA in complex with d-(G1ACTAATTGAC11).d-(G12TCATTAGTC22) has been determined by restrained molecular dynamics and relaxation matrix calculations using experimental NOE distance and torsion angle constraints derived from 1H NMR spectroscopy. The final input data consisted of a total of 858 distance and 189 dihedral angle constraints, an average of 46 constraints per residue. In the ensemble of 20 final structures, there were no distance constraint violations >0.06 A or torsion angle violations >0.8 degrees. The average pairwise root mean square deviation (RMSD) over all 20 structures for the binding site region is 0.57 A (average RMSD from the mean: 0.39 A). Although the DNA is very B-like, the sugar-phosphate backbone torsion angles beta, epsilon, and zeta are distorted from standard values in the binding site region. The structure reveals site-specific bonding of duocarmycin SA at the N3 position of adenine 19 in the AT-rich minor groove of the duplex and binding stabilization via hydrophobic interactions. Comparisons have been made to the structure of a closely related complex of duocarmycin A bound to an AT-rich DNA duplex. These results provide insights into critical aspects of the alkylation site selectivity and source of catalysis of the DNA alkylating agents, and the unusual stability of the resulting adducts.
 
  Selected figure(s)  
 
Figure 12.
Figure 12. Population of two conformations by the DSA methyl ester in the DSA-DNA complex. 65% of the structures occupy the orientation shown in red and the remainder occupy the cyan orientation. The two alter- nate hydrogen bonding interactions are indicated, along with the corresponding distance between T4H10 and DSA O15CH 3.
Figure 14.
Figure 14. Schematic diagram of the alkylation (and back reaction) of an adenine residue by DSA.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (1997, 272, 237-252) copyright 1997.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21547666 T.Choi, and E.Ma (2011).
Structural influence of indole C5-N-substitutents on the cytotoxicity of seco-duocarmycin analogs.
  Arch Pharm Res, 34, 357-367.  
20381346 W.M.Robertson, D.B.Kastrinsky, I.Hwang, and D.L.Boger (2010).
Synthesis and evaluation of a series of C5'-substituted duocarmycin SA analogs.
  Bioorg Med Chem Lett, 20, 2722-2725.  
19641906 L.F.Tietze, B.Krewer, and H.Frauendorf (2009).
Investigation of the transformations of a novel anti-cancer agent combining HPLC, HPLC-MS and direct ESI-HRMS analyses.
  Anal Bioanal Chem, 395, 437-448.  
18160662 A.V.Vargiu, P.Ruggerone, A.Magistrato, and P.Carloni (2008).
Sliding of alkylating anticancer drugs along the minor groove of DNA: new insights on sequence selectivity.
  Biophys J, 94, 550-561.  
16791311 K.Spiegel, and A.Magistrato (2006).
Modeling anticancer drug-DNA interactions via mixed QM/MM molecular dynamics simulations.
  Org Biomol Chem, 4, 2507-2517.  
16960904 L.F.Tietze, B.Krewer, H.Frauendorf, F.Major, and I.Schuberth (2006).
Investigation of reactivity and selectivity of DNA-alkylating duocarmycin analogues by high-resolution mass spectrometry.
  Angew Chem Int Ed Engl, 45, 6570-6574.  
16557312 P.Cimino, G.Bifulco, R.Riccio, L.Gomez-Paloma, and V.Barone (2006).
On the role of stereo-electronic effects in tuning the selectivity and rate of DNA alkylation by duocarmycins.
  Org Biomol Chem, 4, 1242-1251.  
14613110 C.Bassarello, P.Cimino, G.Bifulco, D.L.Boger, J.A.Smith, W.J.Chazin, and L.Gomez-Paloma (2003).
NMR structure of the (+)-CPI-indole/d(GACTAATTGAC)-d(GTCAATTAGTC) covalent complex.
  Chembiochem, 4, 1188-1193.  
11454471 D.L.Boger, F.Stauffer, and M.P.Hedrick (2001).
Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
  Bioorg Med Chem Lett, 11, 2021-2024.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer